Low-Dose Olanzapine for Anorexia Nervosa

<p>In this episode, we examine the tolerability, safety, and effectiveness of low-dose olanzapine in adolescents with anorexia nervosa (AN). Learn about the potential benefits and risks of using olanzapine in AN patients and the importance of a multidisciplinary approach in treating this challenging population.</p> <p>Faculty: David Rosenberg, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC226" target="_blank" rel="noopener"><strong>Learn more about our membership here</strong></a></li> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/publication/cap-smart-takes-vol-05-2744?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC226" target="_blank" rel="noopener"><strong>Earn 0.5 CMEs: CAP Smart Takes Vol. 05</strong></a></li> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/section/low-dose-olanzapine-for-treating-adolescents-with-anorexia-nervosa-2744-5319?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC226" target="_blank" rel="noopener"><strong>Low-Dose Olanzapine for Treating Adolescents With Anorexia Nervosa</strong></a></li> </ul>